🇺🇸 FDA
Patent

US 12029732

Treatment of vascular and lymphatic disease

granted A61KA61K31/428A61K31/429

Quick answer

US patent 12029732 (Treatment of vascular and lymphatic disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/428, A61K31/429, A61P, A61P7/10